+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pharmaceutical Plastic Packaging Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user and Region (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 220 Pages
  • August 2023
  • Region: Global
  • Fairfield Market Research
  • ID: 5854477

The analyst predicts a robust expansion for the global pharmaceutical plastic packaging market in the coming years. Accounting for nearly half of the entire pharmaceutical packaging market, the pharmaceutical plastic packaging segment is poised to grow substantially in the wake of the pharmaceutical industry's burgeoning expansion. The rising prevalence of chronic diseases like cancer, diabetes, and cardiovascular diseases is driving the growth of the pharmaceutical sector, thereby extending the market's growth potential. Technological and scientific advancements are further fueling the growth of the global pharmaceutical plastic packaging market, making it a promising industry for the future.


Key Report Findings


  • The global pharmaceutical plastic packaging market has surpassed [value].
  • Rapid technological advances hold immense potential to drive market expansion.
  • The plastic bottles segment is likely to emerge as the leading segment due to its shatter resistance, moldability, and greater strength.
  • North America is expected to consolidate a strong foothold in the global pharmaceutical plastic packaging market.
  • Amcor plc, Becton, Dickinson and Company, AptarGroup, Inc., and Drug Plastics Group are some of the leaders in the pharmaceutical plastic packaging industry.

Growth Drivers


The utilization of nano-drug delivery systems, leveraging nanoparticles for targeted delivery and controlled release of therapeutic agents, is gaining prominence. This technology shows potential in the treatment of cancer, cardiovascular diseases, diabetes, and various microbial and inflammatory diseases. Additionally, child-resistant packaging (CRP) is extensively used to prevent children from handling dangerous items. The adoption of CRP is mandated for prescription drugs, nicotine-based products, and over-the-counter medications in various developed countries, further driving the pharmaceutical plastic packaging market.


Accentuation on Primary Pharmaceutical Packaging


Primary pharmaceutical packaging solutions, such as plastic bottles, prefilled syringes, and blister packaging, are in high demand. The growing popularity of pre-fillable syringes and pre-fillable inhalers is boosting the global pharmaceutical plastic packaging market. Innovations in biotechnology for injectable parenteral therapies and increased demand for high visibility unit dosage packaging for diseases like diabetes are creating significant business opportunities for market players.


Plastics Remains an Ideal Raw Material


Plastic is the preferred raw material in the pharmaceutical plastic packaging market due to its design flexibility and affordability. It offers impeccable properties such as rigidity, strength, shatter resistance, moldability, and light-weighting. The shatter resistance of plastic makes it suitable for transportation, while its moldability adds strength and efficiency necessary for shielding against vapor and gas.


Overview of Key Segments


Plastic bottles are the most popular packaging item for pharmaceuticals, suitable for storing drugs in liquid and solid forms. The plastic bottles segment is expected to dominate the market, catering to various applications such as nasal spray and ophthalmic drops. The growing prevalence of communicable diseases, patient compliance, and convenience with oral drug delivery are key drivers for the plastic bottles segment.


Nasal Drugs to Spearhead Dominance


Nasal drugs, available in liquid and powder form, are gaining traction due to their higher stability and promising device developments. Nasal drug delivery containers, also known as nasal sprays, offer controlled delivery of therapeutic agents.


Growth Opportunities Across Regions


North America, with a significant number of pharmaceutical plastic bottle manufacturers, is a hub for pharmaceutical manufacturing. The region is expected to lead the market with extensive in-house production capabilities. Asia Pacific is projected to register the fastest growth due to rising awareness, increasing disposable income, and government initiatives in countries like China and India.


Leading Industry Participants


Prominent players in the global pharmaceutical plastic packaging market include Amcor plc, Becton, Dickinson and Company, AptarGroup, Inc., Drug Plastics Group, Gerresheimer AG, Schott AG, Owens Illinois, Inc., West Pharmaceutical Services, Inc., Berry Global, Inc., WestRock Company, SGD Pharma, International Paper, Comar, LLC, CCL Industries, Inc., and Vetter Pharma International. These players are undertaking strategic initiatives to expand market penetration and develop innovative products.

Table of Contents

1. Executive Summary
1.1. Global Pharmaceutical Packaging Market Snapshot
1.2. Key Market Trends
1.3. Future Projections
1.4. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.1.1. Driver A
2.2.1.2. Driver B
2.2.1.3. Driver C
2.2.2. Restraints
2.2.2.1. Restraint 1
2.2.2.2. Restraint 2
2.2.3. Market Opportunities Matrix
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. Covid-19 Impact Analysis
2.5.1. Pre-covid and Post-covid Scenario
2.5.2. Supply Impact
2.5.3. Demand Impact
2.6. Government Regulations
2.7. Technology Landscape
2.8. Share of Pharmaceutical Packaging in Parent Market
2.9. Raw Material Analysis
2.10. Economic Analysis
3. Production Output and Trade Statistics, 2018 - 2021
3.1. Packaging Supply-Demand Analysis
3.2. Regional Production Statistics
3.2.1. North America
3.2.2. Europe
3.2.3. Asia Pacific
3.2.4. Latin America
3.2.5. Middle East & Africa
4. Price Trends Analysis and Future Projects, 2018 - 2030
4.1. Key Highlights
4.2. Prominent Factors Affecting Prices
4.3. By Material
4.4. By Region
5. Global Pharmaceutical Packaging Market Outlook, 2018 - 2030
5.1. Global Pharmaceutical Packaging Market Outlook, by Material, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
5.1.1. Key Highlights
5.1.1.1. Glass
5.1.1.2. Plastic
5.1.1.3. Metal
5.1.1.4. Paper & Cardboard
5.1.1.5. Misc.
5.1.2. BPS Analysis/Market Attractiveness Analysis
5.2. Global Pharmaceutical Packaging Market Outlook, by Applications, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
5.2.1. Key Highlights
5.2.1.1. Bottle & Jars
5.2.1.2. Boxes & Cartons
5.2.1.3. Blister
5.2.1.4. Prefillable Syringes
5.2.1.5. Pouches
5.2.1.6. Parenteral Vials & Ampuls
5.2.1.7. Misc. (Prefillable Inhalers, etc.)
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Global Pharmaceutical Packaging Market Outlook, by Region, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
5.3.1. Key Highlights
5.3.1.1. North America
5.3.1.2. Europe
5.3.1.3. Asia Pacific
5.3.1.4. Latin America
5.3.1.5. Middle East & Africa
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. North America Pharmaceutical Packaging Market Outlook, 2018 - 2030
6.1. North America Pharmaceutical Packaging Market Outlook, by Material, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
6.1.1. Key Highlights
6.1.1.1. Glass
6.1.1.2. Plastic
6.1.1.3. Metal
6.1.1.4. Paper & Cardboard
6.1.1.5. Misc.
6.2. North America Pharmaceutical Packaging Market Outlook, by Application, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
6.2.1. Key Highlights
6.2.1.1. Bottle & Jars
6.2.1.2. Boxes & Cartons
6.2.1.3. Blister
6.2.1.4. Prefillable Syringes
6.2.1.5. Pouches
6.2.1.6. Parenteral Vials & Ampuls
6.2.1.7. Misc. (Prefillable Inhalers, etc.)
6.3. North America Pharmaceutical Packaging Market Outlook, by Country, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
6.3.1. Key Highlights
6.3.1.1. U.S.
6.3.1.2. Canada
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Pharmaceutical Packaging Market Outlook, 2018 - 2030
7.1. Europe Pharmaceutical Packaging Market Outlook, by Material, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
7.1.1. Key Highlights
7.1.1.1. Glass
7.1.1.2. Plastic
7.1.1.3. Metal
7.1.1.4. Paper & Cardboard
7.1.1.5. Misc.
7.1.2. BPS Analysis/Market Attractiveness Analysis
7.2. Europe Pharmaceutical Packaging Market Outlook, by Application, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
7.2.1. Key Highlights
7.2.1.1. Bottle & Jars
7.2.1.2. Boxes & Cartons
7.2.1.3. Blister
7.2.1.4. Prefillable Syringes
7.2.1.5. Pouches
7.2.1.6. Parenteral Vials & Ampuls
7.2.1.7. Misc. (Prefillable Inhalers, etc.)
7.3. Europe Pharmaceutical Packaging Market Outlook, by Country, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
7.3.1. Key Highlights
7.3.1.1. Germany
7.3.1.2. France
7.3.1.3. U.K.
7.3.1.4. Italy
7.3.1.5. Spain
7.3.1.6. Turkey
7.3.1.7. Russia
7.3.1.8. Rest of Europe
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Pharmaceutical Packaging Market Outlook, 2018 - 2030
8.1. Asia Pacific Pharmaceutical Packaging Market Outlook, by Material, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
8.1.1. Key Highlights
8.1.1.1. Glass
8.1.1.2. Plastic
8.1.1.3. Metal
8.1.1.4. Paper & Cardboard
8.1.1.5. Misc.
8.2. Asia Pacific Pharmaceutical Packaging Market Outlook, by Application, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
8.2.1. Key Highlights
8.2.1.1. Bottle & Jars
8.2.1.2. Boxes & Cartons
8.2.1.3. Blister
8.2.1.4. Prefillable Syringes
8.2.1.5. Pouches
8.2.1.6. Parenteral Vials & Ampuls
8.2.1.7. Misc. (Prefillable Inhalers, etc.)
8.3. Asia Pacific Pharmaceutical Packaging Market Outlook, by Country, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
8.3.1. Key Highlights
8.3.1.1. China
8.3.1.2. Japan
8.3.1.3. South Korea
8.3.1.4. India
8.3.1.5. Southeast Asia
8.3.1.6. Rest of Asia Pacific
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Pharmaceutical Packaging Market Outlook, 2018 - 2030
9.1. Latin America Pharmaceutical Packaging Market Outlook, by Material, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
9.1.1. Key Highlights
9.1.1.1. Glass
9.1.1.2. Plastic
9.1.1.3. Metal
9.1.1.4. Paper & Cardboard
9.1.1.5. Misc.
9.2. Latin America Pharmaceutical Packaging Market Outlook, by Application, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
9.2.1. Key Highlights
9.2.1.1. Bottle & Jars
9.2.1.2. Boxes & Cartons
9.2.1.3. Blister
9.2.1.4. Prefillable Syringes
9.2.1.5. Pouches
9.2.1.6. Parenteral Vials & Ampuls
9.2.1.7. Misc. (Prefillable Inhalers, etc.)
9.3. Latin America Pharmaceutical Packaging Market Outlook, by Country, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
9.3.1. Key Highlights
9.3.1.1. Brazil
9.3.1.2. Mexico
9.3.1.3. Rest of Latin America
9.3.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Pharmaceutical Packaging Market Outlook, 2018 - 2030
10.1. Middle East & Africa Pharmaceutical Packaging Market Outlook, by Material, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
10.1.1. Key Highlights
10.1.1.1. Glass
10.1.1.2. Plastic
10.1.1.3. Metal
10.1.1.4. Paper & Cardboard
10.1.1.5. Misc.
10.2. Middle East & Africa Pharmaceutical Packaging Market Outlook, by Application, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
10.2.1. Key Highlights
10.2.1.1. Bottle & Jars
10.2.1.2. Boxes & Cartons
10.2.1.3. Blister
10.2.1.4. Prefillable Syringes
10.2.1.5. Pouches
10.2.1.6. Parenteral Vials & Ampuls
10.2.1.7. Misc. (Prefillable Inhalers, etc.)
10.2.2. BPS Analysis/Market Attractiveness Analysis
10.3. Middle East & Africa Pharmaceutical Packaging Market Outlook, by Country, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
10.3.1. Key Highlights
10.3.1.1. GCC
10.3.1.2. South Africa
10.3.1.3. Rest of Middle East & Africa
10.3.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. Company Market Share Analysis, 2021
11.2. Competitive Dashboard
11.3. Product vs Application Heatmap
11.4. Company Profiles
11.4.1. Amcor Plc
11.4.1.1. Company Overview
11.4.1.2. Product Portfolio
11.4.1.3. Financial Overview
11.4.1.4. Business Strategies and Development
11.4.2. WestRock Company SGD S.A.
11.4.3. Becton Dickinson and Company
11.4.4. Berry Global Group, Inc
11.4.5. Mondi group
11.4.6. Sealed Air Corporation
11.4.7. Gerresheimer Group
11.4.8. Nipro Corporation
11.4.9. Gilpack
11.4.10. Catalent, Inc.
11.4.11. West Pharmaceutical Services, Inc.
11.4.12. UDG Healthcare
11.4.13. AptarGroup Inc.
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • WestRock Company SGD S.A.
  • Becton Dickinson and Company
  • Berry Global Group, Inc
  • Mondi group
  • Sealed Air Corporation
  • Gerresheimer Group
  • Nipro Corporation
  • Gilpack
  • Catalent, Inc.
  • West Pharmaceutical Services, Inc.
  • UDG Healthcare
  • AptarGroup Inc.

Methodology

Loading
LOADING...